118 related articles for article (PubMed ID: 33398447)
1. MRI-guided stereotactic radiation therapy for hepatocellular carcinoma: a feasible and safe innovative treatment approach.
Boldrini L; Romano A; Mariani S; Cusumano D; Catucci F; Placidi L; Mattiucci GC; Chiloiro G; Cellini F; Gambacorta MA; Indovina L; Valentini V
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2057-2068. PubMed ID: 33398447
[TBL] [Abstract][Full Text] [Related]
2. A prospective registry study of stereotactic magnetic resonance guided radiotherapy (MRgRT) for primary liver tumors.
Bordeau K; Michalet M; Dorion V; Keskes A; Valdenaire S; Debuire P; Cantaloube M; Cabaillé M; Draghici R; Ychou M; Assenat E; Jarlier M; Gourgou S; Guiu B; Ursic-Bedoya J; Aillères N; Fenoglietto P; Azria D; Riou O
Radiother Oncol; 2023 Dec; 189():109912. PubMed ID: 37739315
[TBL] [Abstract][Full Text] [Related]
3. Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma.
Yamashita H; Onishi H; Murakami N; Matsumoto Y; Matsuo Y; Nomiya T; Nakagawa K;
J Radiat Res; 2015 May; 56(3):561-7. PubMed ID: 25691453
[TBL] [Abstract][Full Text] [Related]
4. Local effect of stereotactic body radiotherapy for primary and metastatic liver tumors in 130 Japanese patients.
Yamashita H; Onishi H; Matsumoto Y; Murakami N; Matsuo Y; Nomiya T; Nakagawa K;
Radiat Oncol; 2014 May; 9():112. PubMed ID: 24886477
[TBL] [Abstract][Full Text] [Related]
5. REPeated mAgnetic resonance Image-guided stereotactic body Radiotherapy (MRIg-reSBRT) for oligometastatic patients: REPAIR, a mono-institutional retrospective study.
Chiloiro G; Panza G; Boldrini L; Romano A; Placidi L; Nardini M; Galetto M; Votta C; Campitelli M; Cellini F; Massaccesi M; Gambacorta MA
Radiat Oncol; 2024 Apr; 19(1):52. PubMed ID: 38671526
[TBL] [Abstract][Full Text] [Related]
6. Real-time Magnetic Resonance-guided Liver Stereotactic Body Radiation Therapy: An Institutional Report Using a Magnetic Resonance-Linac System.
Feldman AM; Modh A; Glide-Hurst C; Chetty IJ; Movsas B
Cureus; 2019 Sep; 11(9):e5774. PubMed ID: 31723533
[TBL] [Abstract][Full Text] [Related]
7. Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Tumors: Initial Clinical Experience and Patient-Reported Outcomes.
Weykamp F; Hoegen P; Klüter S; Spindeldreier CK; König L; Seidensaal K; Regnery S; Liermann J; Rippke C; Koerber SA; Buchele C; Debus J; Hörner-Rieber J
Front Oncol; 2021; 11():610637. PubMed ID: 34178616
[TBL] [Abstract][Full Text] [Related]
8. Proton Beam Therapy and Photon-Based Magnetic Resonance Image-Guided Radiation Therapy: The Next Frontiers of Radiation Therapy for Hepatocellular Carcinoma.
Zaki P; Chuong MD; Schaub SK; Lo SS; Ibrahim M; Apisarnthanarax S
Technol Cancer Res Treat; 2023; 22():15330338231206335. PubMed ID: 37908130
[TBL] [Abstract][Full Text] [Related]
9. Role of Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma.
Abualnil AY; Kumar R; George MA; Lalos A; Shah MM; Deek MP; Jabbour SK
Surg Oncol Clin N Am; 2024 Jan; 33(1):173-195. PubMed ID: 37945142
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma: a meta-regression.
Malik A; Jairam MP; Chow R; Mirshahvalad SA; Veit-Haibach P; Simone CB
Future Oncol; 2023 Feb; 19(4):279-287. PubMed ID: 36916490
[No Abstract] [Full Text] [Related]
11. The Use of MR-Guided Radiation Therapy for Liver Cancer.
Prime S; Schiff JP; Hosni A; Stanescu T; Dawson LA; Henke LE
Semin Radiat Oncol; 2024 Jan; 34(1):36-44. PubMed ID: 38105091
[TBL] [Abstract][Full Text] [Related]
12. Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac - Feasibility, workflow data and patient acceptance.
Gani C; Boeke S; McNair H; Ehlers J; Nachbar M; Mönnich D; Stolte A; Boldt J; Marks C; Winter J; Künzel LA; Gatidis S; Bitzer M; Thorwarth D; Zips D
Clin Transl Radiat Oncol; 2021 Jan; 26():55-61. PubMed ID: 33319073
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes after online adaptive MR-guided stereotactic body radiotherapy for pancreatic tumors on a 1.5 T MR-linac.
Eijkelenkamp H; Grimbergen G; Daamen LA; Heerkens HD; van de Ven S; Mook S; Meijer GJ; Molenaar IQ; van Santvoort HC; Paulson E; Erickson BA; Verkooijen HM; Hall WA; Intven MPW
Front Oncol; 2023; 13():1040673. PubMed ID: 37854684
[TBL] [Abstract][Full Text] [Related]
14. A Phase II Study of Optimized Individualized Adaptive Radiotherapy for Hepatocellular Carcinoma.
Herr DJ; Wang C; Mendiratta-Lala M; Matuszak M; Mayo CS; Cao Y; Parikh ND; Ten Haken R; Owen D; Evans JR; Stanescu T; Yan M; Dawson LA; Schipper M; Lawrence TS; Cuneo KC
Clin Cancer Res; 2023 Oct; 29(19):3852-3858. PubMed ID: 37471457
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance-guided radiation therapy: A review.
Chin S; Eccles CL; McWilliam A; Chuter R; Walker E; Whitehurst P; Berresford J; Van Herk M; Hoskin PJ; Choudhury A
J Med Imaging Radiat Oncol; 2020 Feb; 64(1):163-177. PubMed ID: 31646742
[TBL] [Abstract][Full Text] [Related]
16. Current perspectives on radiotherapy in hepatocellular carcinoma management: a comprehensive review.
Kim D; Kim JS
J Liver Cancer; 2024 Mar; 24(1):33-46. PubMed ID: 38523467
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Advantages and Challenges of MR-Guided Radiotherapy in Non-Small-Cell Lung Cancer: Who are the Optimal Candidates?
Wu TC; Smith LM; Woolf D; Faivre-Finn C; Lee P
Semin Radiat Oncol; 2024 Jan; 34(1):56-63. PubMed ID: 38105094
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic Body Radiotherapy for Hepatocellular Carcinoma Resulting in a Durable Relapse-Free Survival: A Case Report.
Francis S; Williams N; Anker CJ; Shaaban A; Kim R; Shrieve D; Tward J
Cureus; 2016 Oct; 8(10):e841. PubMed ID: 27909629
[TBL] [Abstract][Full Text] [Related]
19. MR-Guided Radiotherapy for Liver Malignancies.
Boldrini L; Corradini S; Gani C; Henke L; Hosni A; Romano A; Dawson L
Front Oncol; 2021; 11():616027. PubMed ID: 33869001
[TBL] [Abstract][Full Text] [Related]
20. Ablative radiotherapy for liver tumors using stereotactic MRI-guidance: A prospective phase I trial.
van Dams R; Wu TC; Kishan AU; Raldow AC; Chu FI; Hernandez J; Cao M; Lamb JM; Mikaeilian A; Low DA; Steinberg ML; Lee P
Radiother Oncol; 2022 May; 170():14-20. PubMed ID: 34107296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
